Similar articles

• The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.

  Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL. Yale JF, et al. Ann Intern Med. 2001 May 1;134(9 Pt 1):737-45. doi: 10.7326/0003-4819-134-9_part_1-200105010-00010. Ann Intern Med. 2001. PMID: 11329231 Clinical Trial.
• Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

  Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD. Chu NV, et al. Diabetes Care. 2002 Mar;25(3):542-9. doi: 10.2337/diacare.25.3.542. Diabetes Care. 2002. PMID: 11874944 Clinical Trial.
• Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice.

  Hershon KS, Hershon PM. Hershon KS, et al. Endocr Pract. 2000 Jan-Feb;6(1):20-5. doi: 10.4158/EP.6.1.20. Endocr Pract. 2000. PMID: 11419922
• The polycystic ovary syndrome: treatment with insulin sensitizing agents.

  Iuorno MJ, Nestler JE. Iuorno MJ, et al. Diabetes Obes Metab. 1999 May;1(3):127-36. doi: 10.1046/j.1463-1326.1999.00026.x. Diabetes Obes Metab. 1999. PMID: 11220291 Review. No abstract available.
• [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].

  Ohmura E, Hosaka D, Imai Y, Kawazu S. Ohmura E, et al. Nihon Rinsho. 2002 Sep;60 Suppl 9:470-5. Nihon Rinsho. 2002. PMID: 12387036 Review. Japanese. No abstract available.